Cathay Biotech (China) Performance
| 688065 Stock | 39.30 1.20 3.15% |
The firm shows a Beta (market volatility) of 0.48, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cathay Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cathay Biotech is expected to be smaller as well. At this point, Cathay Biotech has a negative expected return of -0.21%. Please make sure to confirm Cathay Biotech's total risk alpha, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to decide if Cathay Biotech performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Cathay Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Forward Dividend Yield 0.0048 | Payout Ratio 0.2794 | Last Split Factor 1.4:1 | Forward Dividend Rate 0.19 | Ex Dividend Date 2024-07-24 |
1 | Cathay Biotech Inc.s Stock Is Rallying But Financials Look Ambiguous Will The Momentum Continue - Simply Wall St | 11/27/2024 |
2 | Does Cathay Biotech Have A Healthy Balance Sheet - Simply Wall St | 01/08/2025 |
| Begin Period Cash Flow | 6.2 B |
Cathay |
Cathay Biotech Relative Risk vs. Return Landscape
If you would invest 4,550 in Cathay Biotech on October 20, 2024 and sell it today you would lose (620.00) from holding Cathay Biotech or give up 13.63% of portfolio value over 90 days. Cathay Biotech is generating negative expected returns and assumes 1.9992% volatility on return distribution over the 90 days horizon. Simply put, 17% of stocks are less volatile than Cathay, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Cathay Biotech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cathay Biotech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cathay Biotech, and traders can use it to determine the average amount a Cathay Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1028
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 688065 |
Estimated Market Risk
| 2.0 actual daily | 17 83% of assets are more volatile |
Expected Return
| -0.21 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cathay Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cathay Biotech by adding Cathay Biotech to a well-diversified portfolio.
Cathay Biotech Fundamentals Growth
Cathay Stock prices reflect investors' perceptions of the future prospects and financial health of Cathay Biotech, and Cathay Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cathay Stock performance.
| Return On Equity | 0.026 | ||||
| Return On Asset | 0.0106 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 19.59 B | ||||
| Shares Outstanding | 583.38 M | ||||
| Price To Book | 2.01 X | ||||
| Price To Sales | 8.30 X | ||||
| Revenue | 2.11 B | ||||
| Gross Profit | 846.65 M | ||||
| EBITDA | 608.83 M | ||||
| Net Income | 366.52 M | ||||
| Total Debt | 1.53 B | ||||
| Book Value Per Share | 19.74 X | ||||
| Cash Flow From Operations | 569.45 M | ||||
| Earnings Per Share | 0.68 X | ||||
| Total Asset | 18.83 B | ||||
| Retained Earnings | 2.07 B | ||||
About Cathay Biotech Performance
By analyzing Cathay Biotech's fundamental ratios, stakeholders can gain valuable insights into Cathay Biotech's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cathay Biotech has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cathay Biotech has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Cathay Biotech is entity of China. It is traded as Stock on SHG exchange.Things to note about Cathay Biotech performance evaluation
Checking the ongoing alerts about Cathay Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cathay Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cathay Biotech generated a negative expected return over the last 90 days | |
| Cathay Biotech is unlikely to experience financial distress in the next 2 years | |
| About 61.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Does Cathay Biotech Have A Healthy Balance Sheet - Simply Wall St |
- Analyzing Cathay Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cathay Biotech's stock is overvalued or undervalued compared to its peers.
- Examining Cathay Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cathay Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cathay Biotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cathay Biotech's stock. These opinions can provide insight into Cathay Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cathay Stock analysis
When running Cathay Biotech's price analysis, check to measure Cathay Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cathay Biotech is operating at the current time. Most of Cathay Biotech's value examination focuses on studying past and present price action to predict the probability of Cathay Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cathay Biotech's price. Additionally, you may evaluate how the addition of Cathay Biotech to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |